Ahmad F, Azevedo J L, Cortright R, Dohm G L, Goldstein B J
Dorrance H. Hamilton Research Laboratories, Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
J Clin Invest. 1997 Jul 15;100(2):449-58. doi: 10.1172/JCI119552.
Obese human subjects have increased protein-tyrosine phosphatase (PTPase) activity in adipose tissue that can dephosphorylate and inactivate the insulin receptor kinase. To extend these findings to skeletal muscle, we measured PTPase activity in the skeletal muscle particulate fraction and cytosol from a series of lean controls, insulin-resistant obese (body mass index > 30) nondiabetic subjects, and obese individuals with non-insulin-dependent diabetes. PTPase activities in subcellular fractions from the nondiabetic obese subjects were increased to 140-170% of the level in lean controls (P < 0.05). In contrast, PTPase activity in both fractions from the obese subjects with non-insulin-dependent diabetes was significantly decreased to 39% of the level in controls (P < 0.05). By immunoblot analysis, leukocyte antigen related (LAR) and protein-tyrosine phosphatase 1B had the greatest increase (threefold) in the particulate fraction from obese, nondiabetic subjects, and immunodepletion of this fraction using an affinity-purified antibody directed at the cytoplasmic domain of leukocyte antigen related normalized the PTPase activity when compared to the activity from control subjects. These findings provide further support for negative regulation of insulin action by specific PTPases in the pathogenesis of insulin resistance in human obesity, while other regulatory mechanisms may be operative in the diabetic state.
肥胖人体受试者的脂肪组织中蛋白酪氨酸磷酸酶(PTPase)活性增加,该酶可使胰岛素受体激酶去磷酸化并使其失活。为了将这些发现扩展到骨骼肌,我们测量了一系列瘦素对照组、胰岛素抵抗肥胖(体重指数>30)非糖尿病受试者以及非胰岛素依赖型糖尿病肥胖个体的骨骼肌微粒体部分和胞质溶胶中的PTPase活性。非糖尿病肥胖受试者亚细胞部分的PTPase活性增加到瘦素对照组水平的140 - 170%(P < 0.05)。相比之下,非胰岛素依赖型糖尿病肥胖受试者两个部分的PTPase活性均显著降低至对照组水平的39%(P < 0.05)。通过免疫印迹分析,白细胞抗原相关蛋白(LAR)和蛋白酪氨酸磷酸酶1B在肥胖非糖尿病受试者的微粒体部分增加最多(三倍),并且使用针对白细胞抗原相关蛋白胞质结构域的亲和纯化抗体对该部分进行免疫去除后,与对照组受试者的活性相比,PTPase活性恢复正常。这些发现进一步支持了在人类肥胖胰岛素抵抗发病机制中特定PTPases对胰岛素作用的负调节,而其他调节机制可能在糖尿病状态下起作用。